Genzyme Tissue Repair - GZTR Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair - GZTR

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tapcon who wrote (186)	6/16/1999 10:38:00 AM
From: BWAC	Read Replies (1) of 405

Epicel First introduced in 1987, these epidermal grafts are grown from a patient's own skin cells and therefore are not rejected by the patient's immune system. Starting with a biopsy of healthy skin about the size of a postage stamp, Genzyme Tissue Repair can grow enough skin to cover a patients entire body surface. The process takes as little as 16 days. To produce the skin grafts, cells from the biopsy of healthy skin are isolated, placed into culture in individual flasks, nutritionally supported, and allowed to grow together to form sheets of tissue about the size of playing cards. Epicel skin grafts are used routinely at major burn centers in the United States, France, and Germany.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next